Weekend reads: “Weaponized transparency;” fighting academic spam with humor; NIH cracks down

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, would you consider a tax-deductible donation of $25, or a recurring donation of an amount of your choosing, to support it? Thanks in advance. The week at Retraction Watch featured a major case of misconduct at The Ohio State University, … Continue reading Weekend reads: “Weaponized transparency;” fighting academic spam with humor; NIH cracks down

PNAS wouldn’t let authors cite unpublished manuscript. Now, it admits it was wrong.

Question: Do you value Retraction Watch? If so, would you consider a tax-deductible donation of $25, or a recurring donation of an amount of your choosing, to support us? When researchers submitted a paper about a type of microparticle to PNAS, they wanted to give credit where it was due, and cite an unpublished manuscript … Continue reading PNAS wouldn’t let authors cite unpublished manuscript. Now, it admits it was wrong.

Caught Our Notice: Yes, a 20-year-old article is wrong — but it won’t be corrected online

Title: AMPA receptor-mediated regulation of a Gi-protein in cortical neurons What Caught Our Attention:  Usually, when journals publish corrections to articles, they also correct the original article, except when the original is unavailable online.  When Nature noticed that some figure panels in a 20-year-old paper were duplicated, it flagged the issue for readers — but … Continue reading Caught Our Notice: Yes, a 20-year-old article is wrong — but it won’t be corrected online

Authors claim clinical trial data came from one center. It came from three.

A BMJ journal has retracted a 2017 paper that made a false claim about the clinical trial in question.  The Acupuncture in Medicine paper reported the results of a clinical trial about the impact of acupuncture and Chinese herbal medicine on stroke, gathered from one center. However, in November, the editors of the journal discovered that … Continue reading Authors claim clinical trial data came from one center. It came from three.

Weekend reads: Fallout from misconduct at Duke; does journal prestige matter?; the data on fake peer review

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, would you consider a tax-deductible donation of $25, or a recurring donation of an amount of your choosing, to support it?  The week at Retraction Watch featured the retraction of a paper on a “gut makeover,” a retraction following … Continue reading Weekend reads: Fallout from misconduct at Duke; does journal prestige matter?; the data on fake peer review

Journal retracts study linking “gut makeover” to weight loss, improved health

Over the objections of the authors, PLOS ONE has retracted a paper linking a diet designed to restore healthy gut bacteria to weight loss and other benefits. The study, published in June 2017, claimed to show that a “Microbiome restoration diet improves digestion, cognition and physical and emotional wellbeing.” The diet was one championed by … Continue reading Journal retracts study linking “gut makeover” to weight loss, improved health

Figures in cancer paper at root of newly failed compound called into question

How much role did a potentially problematic paper play in the demise of a once-promising compound? Researchers are questioning the validity of a high-profile article, published by Nature in 2006. Although the letter is 12 years old, the concerns have current implications: It was among the early evidence used to develop a cancer compound that … Continue reading Figures in cancer paper at root of newly failed compound called into question

Over a dozen editorial board members resigned when a journal refused to retract a paper. Today, it’s retracted.

Following a massive editorial protest, Scientific Reports is admitting its handling of a disputed paper was “insufficient and inadequate,” and has agreed to retract it. The 2016 paper was initially corrected by the journal, after a researcher at Johns Hopkins University, Michael Beer, accused it of lifting some of his earlier work. After we covered … Continue reading Over a dozen editorial board members resigned when a journal refused to retract a paper. Today, it’s retracted.

“Clear signs of manipulation” in paper co-authored by prominent geneticist

A third paper co-authored by researchers based at a prominent lab whose work has been under investigation on and off for almost three years has been retracted. According to the notice, the university’s investigation found that a 2008 paper in FEBS Letters contained “clear signs of manipulation” in three figures. Research from geneticist David Latchman’s … Continue reading “Clear signs of manipulation” in paper co-authored by prominent geneticist

Delays, arguing over upcoming Cell retraction leave first author “devastated”

After being “blindsided” a few months ago when she was told one of her 2005 papers was going to be retracted, a researcher scrambled to get information about why. And when she didn’t like the answers, she took to PubPeer. Eight days ago, Shalon (Babbitt) Ledbetter, the first author of the 2005 paper published in … Continue reading Delays, arguing over upcoming Cell retraction leave first author “devastated”